Publication List 1984-1994

1984-94, 1995, 1996, 1997, 1998, 1999, 2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022

93	Miyazono K, Ten Dijke P, Ichijo H, Heldin CH. Receptors for transforming growth factor-β. Adv Immunol. 1994;55:181-220.
92	Stenman G, Sahlin P, Olofsson A, Geurts van Kessel A, Miyazono K. Assignment of the gene encoding the latent TGF-β1-binding protein (LTBP1) to human chromosome 2, region p12-->q22. Cytogenet Cell Genet. 1994;66(2):117-9.
91	ten Dijke P, Franzen P, Yamashita H, Ichijo H, Heldin CH, Miyazono K. Serine/threonine kinase receptors. Prog Growth Factor Res. 1994;5(1):55-72.
90	McWhirter A, Colosetti P, Rubin K, Miyazono K, Black C. Collagen type I is not under autocrine control by transforming growth factor-β1 in normal and scleroderma fibroblasts. Lab Invest. 1994 Dec;71(6):885-94.
89	Miyazono K, ten Dijke P, Yamashita H, Heldin CH. Signal transduction via serine/threonine kinase receptors. Semin Cell Biol. 1994 Dec;5(6):389-98.
88	Moren A, Olofsson A, Stenman G, Sahlin P, Kanzaki T, Claesson-Welsh L, ten Dijke P, Miyazono K, Heldin CH. Identification and characterization of LTBP-2, a novel latent transforming growth factor-β-binding protein. J Biol Chem. 1994 Dec 23;269(51):32469-78.
87	Okadome T, Yamashita H, Franzen P, Moren A, Heldin CH, Miyazono K. Distinct roles of the intracellular domains of transforming growth factor-β type I and type II receptors in signal transduction. J Biol Chem. 1994 Dec 9;269(49):30753-6.
86	Yamashita H, ten Dijke P, Franzen P, Miyazono K, Heldin CH. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β. J Biol Chem. 1994 Aug 5;269(31):20172-8.
85	Wataya-Kaneda M, Hashimoto K, Kato M, Miyazono K, Yoshikawa K. Differential localization of TGF-β-precursor isotypes in normal human skin. J Dermatol Sci. 1994 Aug;8(1):38-44.
84	Usuki K, Gonez LJ, Wernstedt C, Moren A, Miyazono K, Claesson-Welsh L, Heldin CH. Structural properties of 3.0 kb and 3.2 kb transcripts encoding platelet-derived endothelial cell growth factor/thymidine phosphorylase in A431 cells. Biochim Biophys Acta. 1994 Jul 21;1222(3):411-4.
83	ten Dijke P, Yamashita H, Sampath TK, Reddi AH, Estevez M, Riddle DL, Ichijo H, Heldin CH, Miyazono K. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem. 1994 Jun 24;269(25):16985-8.
82	Taketazu F, Kato M, Gobl A, Ichijo H, ten Dijke P, Itoh J, Kyogoku M, Ronnelid J, Miyazono K, Heldin CH. Enhanced expression of transforming growth factor-βs and transforming growth factor-β type II receptor in the synovial tissues of patients with rheumatoid arthritis. Lab Invest. 1994 May;70(5):620-30.
81	ten Dijke P, Yamashita H, Ichijo H, Franzen P, Laiho M, Miyazono K, Heldin CH. Characterization of type I receptors for transforming growth factor-β and activin. Science. 1994 Apr 1;264(5155):101-4.
80	Dallas SL, Park-Snyder S, Miyazono K, Twardzik D, Mundy GR, Bonewald LF. Characterization and autoregulation of latent transforming growth factor β (TGFβ) complexes in osteoblast-like cell lines. Production of a latent complex lacking the latent TGFβ-binding protein. J Biol Chem. 1994 Mar 4;269(9):6815-21.
79	Yamazaki M, Minota S, Sakurai H, Miyazono K, Yamada A, Kanazawa I, Kawai M. Expression of transforming growth factor-β1 and its relation to endomysial fibrosis in progressive muscular dystrophy. Am J Pathol. 1994 Feb;144(2):221-6.
78	Taipale J, Miyazono K, Heldin CH, Keski-Oja J. Latent transforming growth factor-β1 associates to fibroblast extracellular matrix via latent TGF-β binding protein. J Cell Biol. 1994 Jan;124(1-2):171-81.
77	Kusakari C, Nose M, Takasaka T, Yuasa R, Kato M, Miyazono K, Fujita T, Kyogoku M. Immunopathological features of palatine tonsil characteristic of IgA nephropathy: IgA1 localization in follicular dendritic cells. Clin Exp Immunol. 1994 Jan;95(1):42-8.
76	Yamashita H, Ichijo H, Grimsby S, Moren A, ten Dijke P, Miyazono K. Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-β. J Biol Chem. 1994 Jan 21;269(3):1995-2001.
75	Miyazono K, Ichijo H, Heldin CH. Transforming growth factor-β: latent forms, binding proteins and receptors. Growth Factors. 1993;8(1):11-22.
74	Franzen P, ten Dijke P, Ichijo H, Yamashita H, Schulz P, Heldin CH, Miyazono K. Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor. Cell. 1993 Nov 19;75(4):681-92.
73	ten Dijke P, Ichijo H, Franzen P, Schulz P, Saras J, Toyoshima H, Heldin CH, Miyazono K. Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene. 1993 Oct;8(10):2879-87.
72	Ichijo H, Yamashita H, ten Dijke P, Eto Y, Heldin CH, Miyazono K. Characterization of in vivo phosphorylation of activin type II receptor. Biochem Biophys Res Commun. 1993 Aug 16;194(3):1508-14.
71	Franzen P, Ichijo H, Miyazono K. Different signals mediate transforming growth factor-β1-induced growth inhibition and extracellular matrix production in prostatic carcinoma cells. Exp Cell Res. 1993 Jul;207(1):1-7.
70	Waltenberger J, Wanders A, Fellstrom B, Miyazono K, Heldin CH, Funa K. Induction of transforming growth factor-β during cardiac allograft rejection. J Immunol. 1993 Jul 15;151(2):1147-57.
69	Ichijo H, Hellman U, Wernstedt C, Gonez LJ, Claesson-Welsh L, Heldin CH, Miyazono K. Molecular cloning and characterization of ficolin, a multimeric protein with fibrinogen- and collagen-like domains. J Biol Chem. 1993 Jul 5;268(19):14505-13.
68	Eklov S, Funa K, Nordgren H, Olofsson A, Kanzaki T, Miyazono K, Nilsson S. Lack of the latent transforming growth factorβ binding protein in malignant, but not benign prostatic tissue. Cancer Res. 1993 Jul 1;53(13):3193-7.
67	Waltenberger J, Miyazono K, Funa K, Wanders A, Fellstrom B, Heldin CH. Transforming growth factor-β and organ transplantation. Transplant Proc. 1993 Apr;25(2):2038-40.
66	Colosetti P, Hellman U, Heldin CH, Miyazono K. Ca²⁺ binding of latent transforming growth factor-β1 binding protein. FEBS Lett. 1993 Apr 5;320(2):140-4.
65	Miyazono K, Heldin CH. The mechanism of action of transforming growth factor-β. Gastroenterol Jpn. 1993 Mar;28 Suppl 4:81-5; discussion 86-7.
64	Flaumenhaft R, Abe M, Sato Y, Miyazono K, Harpel J, Heldin CH, Rifkin DB. Role of the latent TGF-β binding protein in the activation of latent TGF-β by co-cultures of endothelial and smooth muscle cells. J Cell Biol. 1993 Feb;120(4):995-1002.
63	Waltenberger J, Lundin L, Oberg K, Wilander E, Miyazono K, Heldin CH, Funa K. Involvement of transforming growth factor-β in the formation of fibrotic lesions in carcinoid heart disease. Am J Pathol. 1993 Jan;142(1):71-8.
62	Mizoi T, Ohtani H, Miyazono K, Miyazawa M, Matsuno S, Nagura H. Immunoelectron microscopic localization of transforming growth factor β1 and latent transforming growth factor β1 binding protein in human gastrointestinal carcinomas: qualitative difference between cancer cells and stromal cells. Cancer Res. 1993 Jan 1;53(1):183-90.
61	Stenman G, Sahlin P, Dumanski JP, Hagiwara K, Ishikawa F, Miyazono K, Collins VP, Heldin CH. Regional localization of the human platelet-derived endothelial cell growth factor (ECGF1) gene to chromosome 22q13. Cytogenet Cell Genet. 1992;59(1):22-3.
60	Taketazu F, Miyagawa K, Ichijo H, Oshimi K, Mizoguchi H, Hirai H, Miyazono K, Takaku F. Decreased level of transforming growth factor-β in blood lymphocytes of patients with aplastic anemia. Growth Factors. 1992;6(1):85-90.
59	Miyazono K, Heldin CH. Structure, function and possible clinical application of transforming growth factor-β. J Dermatol. 1992 Nov;19(11):644-7.
58	Moren A, Ichijo H, Miyazono K. Molecular cloning and characterization of the human and porcine transforming growth factor-β type III receptors. Biochem Biophys Res Commun. 1992 Nov 30;189(1):356-62.
57	Olofsson A, Miyazono K, Kanzaki T, Colosetti P, Engstrom U, Heldin CH. Transforming growth factor-β1, -β2, and -β3 secreted by a human glioblastoma cell line. Identification of small and different forms of large latent complexes. J Biol Chem. 1992 Sep 25;267(27):19482-8.
56	Hanazono Y, Miyazono K, Piao YF, Taketazu F, Chiba S, Miyagawa K, Hirai H, Sakamoto S, Miura Y, Yazaki Y. Treatment of acute nonlymphocytic leukemia by combination of recombinant human granulocyte colony-stimulating factor and cytotoxic agents: a report of six cases. Int J Hematol. 1992 Jun;55(3):243-8.
55	Usuki K, Saras J, Waltenberger J, Miyazono K, Pierce G, Thomason A, Heldin CH. Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity. Biochem Biophys Res Commun. 1992 May 15;184(3):1311-6.
54	Miyazono K, Thyberg J, Heldin CH. Retention of the transforming growth factor-β1 precursor in the Golgi complex in a latent endoglycosidase H-sensitive form. J Biol Chem. 1992 Mar 15;267(8):5668-75.
53	Miyazono K, Heldin CH. Latent forms of TGF-β: molecular structure and mechanisms of activation. Ciba Found Symp. 1991;157:81-9; discussion 89-92.
52	Heldin CH, Hellman U, Ishikawa F, Miyazono K. Purification, cloning, and expression of platelet-derived endothelial cell growth factor. Methods Enzymol. 1991;198:383-91.
51	Miyazono K, Usuki K, Heldin CH. Platelet-derived endothelial cell growth factor. Prog Growth Factor Res. 1991;3(3):207-17.
50	Hanazono Y, Miyazono K, Tsuchimochi H, Yamaoki K, Miyagawa K, Hirai H, Yazaki Y, Takaku F. Treatment of infective endocarditis with granulocyte colony-stimulating factor. Jpn J Med. 1991 Nov-Dec;30(6):593-6.
49	Heldin CH, Usuki K, Miyazono K. Platelet-derived endothelial cell growth factor. J Cell Biochem. 1991 Nov;47(3):208-10.
48	Ichijo H, Ronnstrand L, Miyagawa K, Ohashi H, Heldin CH, Miyazono K. Purification of transforming growth factor-β1 binding proteins from porcine uterus membranes. J Biol Chem. 1991 Nov 25;266(33):22459-64.
47	Miyazono K, Takaku F. Platelet-derived endothelial cell growth factor: structure and function. Jpn Circ J. 1991 Oct;55(10):1022-6.
46	Usuki K, Miyazono K, Heldin CH. Covalent linkage between nucleotides and platelet-derived endothelial cell growth factor. J Biol Chem. 1991 Oct 25;266(30):20525-31.
45	Shibuya K, Chiba S, Miyagawa K, Kitamura T, Miyazono K, Takaku F. Structural and functional analyses of glycosylation on the distinct molecules of human GM-CSF receptors. Eur J Biochem. 1991 Jun 15;198(3):659-66.
44	Miyazono K, Olofsson A, Colosetti P, Heldin CH. A role of the latent TGF-β1-binding protein in the assembly and secretion of TGF-β1. EMBO J. 1991 May;10(5):1091-101.
43	Hagiwara K, Stenman G, Honda H, Sahlin P, Andersson A, Miyazono K, Heldin CH, Ishikawa F, Takaku F. Organization and chromosomal localization of the human platelet-derived endothelial cell growth factor gene. Mol Cell Biol. 1991 Apr;11(4):2125-32.
42	Taketazu F, Chiba S, Shibuya K, Kuwaki T, Tsumura H, Miyazono K, Miyagawa K, Takaku F. IL-3 specifically inhibits GM-CSF binding to the higher affinity receptor. J Cell Physiol. 1991 Feb;146(2):251-7.
41	Miyazono K, Yuki K, Takaku F, Wernstedt C, Kanzaki T, Olofsson A, Hellman U, Heldin CH. Latent forms of TGF-β: structure and biology. Ann N Y Acad Sci. 1990;593:51-8.
40	Miyazono K, Akagi K. Structure and function of platelet-derived endothelial cell growth factor Acta haematologica Japonica. 1990 Dec;53(8):1456-1459.
39	Kimura S, Matsuda J, Ikematsu S, Miyazono K, Ito A, Nakahata T, Minamitani M, Shimada K, Shiokawa Y, Takaku F. Efficacy of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with AIDS. AIDS. 1990 Dec;4(12):1251-5.
38	Hanazono Y, Hosoi T, Kuwaki T, Matsuki S, Miyazono K, Miyagawa K, Takaku F. Structural analysis of the receptors for granulocyte colony-stimulating factor on neutrophils. Exp Hematol. 1990 Nov;18(10):1097-103.
37	Chiba S, Shibuya K, Miyazono K, Tojo A, Oka Y, Miyagawa K, Takaku F. Affinity purification of human granulocyte macrophage colony-stimulating factor receptor α-chain. Demonstration of binding by photoaffinity labeling. J Biol Chem. 1990 Nov 15;265(32):19777-81.
36	Mitani K, Sato Y, Tojo A, Ishikawa F, Kobayashi Y, Miura Y, Miyazono K, Urabe A, Takaku F. Philadelphia chromosome positive B-cell type malignant lymphoma expressing an aberrant 190 kDa bcr-abl protein. Br J Haematol. 1990 Oct;76(2):221-5.
35	Yuo A, Miyazono K, Urabe A, Takaku F. Characteristics of granulocyte-macrophage colony formation in chronic myelomonocytic leukemia: a comparative study with other myelodysplastic and myeloproliferative disorders. Jpn J Cancer Res. 1990 Aug;81(8):820-6.
34	Sugimoto K, Togawa A, Miyazono K, Itoh K, Amano M, Chiba S, Hino M, Mizoguchi H, Takaku F. Treatment of childhood-onset cyclic neutropenia with recombinant human granulocyte colony-stimulating factor. Eur J Haematol. 1990 Aug;45(2):110-1.
33	Fucharoen S, Kobayashi Y, Fucharoen G, Ohba Y, Miyazono K, Fukumaki Y, Takaku F. A single nucleotide deletion in codon 123 of the β-globin gene causes an inclusion body β-thalassaemia trait: a novel elongated globin chain β^Makabe. Br J Haematol. 1990 Jul;75(3):393-9.
32	Usuki K, Norberg L, Larsson E, Miyazono K, Hellman U, Wernstedt C, Rubin K, Heldin CH. Localization of platelet-derived endothelial cell growth factor in human placenta and purification of an alternatively processed form. Cell Regul. 1990 Jul;1(8):577-84.
31	Kuwaki T, Hosoi T, Hanazono Y, Tsumura H, Ishikawa F, Miyazono K, Miyagawa K, Takaku F. Distribution of human granulocyte colony-stimulating factor receptors on hematopoietic and nonhematopoietic tumor cell lines. Jpn J Cancer Res. 1990 Jun-Jul;81(6-7):560-3.
30	Miyagawa K, Chiba S, Shibuya K, Piao YF, Matsuki S, Yokota J, Terada M, Miyazono K, Takaku F. Frequent expression of receptors for granulocyte-macrophage colony-stimulating factor on human nonhematopoietic tumor cell lines. J Cell Physiol. 1990 Jun;143(3):483-7.
29	Kanzaki T, Olofsson A, Moren A, Wernstedt C, Hellman U, Miyazono K, Claesson-Welsh L, Heldin CH. TGF-β1 binding protein: a component of the large latent complex of TGF-β1 with multiple repeat sequences. Cell. 1990 Jun 15;61(6):1051-61.
28	Ichijo H, Momose F, Miyazono K. Biological effects and binding properties of transforming growth factor-β on human oral squamous cell carcinoma cells. Exp Cell Res. 1990 Apr;187(2):263-9.
27	Chiba S, Shibuya K, Piao YF, Tojo A, Sasaki N, Matsuki S, Miyagawa K, Miyazono K, Takaku F. Identification and cellular distribution of distinct proteins forming human GM-CSF receptor. Cell Regul. 1990 Mar;1(4):327-35.
26	Piao YF, Ichijo H, Miyagawa K, Ohashi H, Takaku F, Miyazono K. Latent form of transforming growth factor-β1 acts as a potent growth inhibitor on a human erythroleukemia cell line. Biochem Biophys Res Commun. 1990 Feb 28;167(1):27-32.
25	Chiba S, Tojo A, Kitamura T, Urabe A, Miyazono K, Takaku F. Characterization and molecular features of the cell surface receptor for human granulocyte-macrophage colony-stimulating factor. Leukemia. 1990 Jan;4(1):29-36.
24	Miyazono K, Takaku F. Platelet-derived growth factors. Blood Rev. 1989 Dec;3(4):269-76.
23	Yuo A, Kitagawa S, Ohsaka A, Ohta M, Miyazono K, Okabe T, Urabe A, Saito M, Takaku F. Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence. Blood. 1989 Nov 1;74(6):2144-9.
22	Usuki K, Heldin NE, Miyazono K, Ishikawa F, Takaku F, Westermark B, Heldin CH. Production of platelet-derived endothelial cell growth factor by normal and transformed human cells in culture. Proc Natl Acad Sci U S A. 1989 Oct;86(19):7427-31.
21	Takahashi T, Ozawa K, Mitani K, Miyazono K, Asano S, Takaku F. B19 parvovirus replicates in erythroid leukemic cells in vitro. J Infect Dis. 1989 Sep;160(3):548-9.
20	Piao YF, Chiba S, Tojo A, Urabe A, Nara N, Miyazono K, Takaku F. Binding properties and proliferative effects of human recombinant granulocyte-macrophage colony-stimulating factor in primary leukemia and lymphoma. Jpn J Cancer Res. 1989 Sep;80(9):887-94.
19	Mitani K, Sato Y, Kobayashi Y, Shibasaki Y, Kasuga M, Inaba T, Hayashi Y, Miura Y, Miyazono K, Hirai H, Urabe A, Takaku F. Heterogeneity in the breakpoints of chromosome 19 among acute leukemic patients with the t(11;19)(q23;p13) translocation. Am J Hematol. 1989 Aug;31(4):253-7.
18	Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K, Piao YF, Miyazono K, Urabe A, Takaku F. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol. 1989 Aug;140(2):323-34.
17	Hino M, Miyazono K, Urabe A, Takaku F. Effects of recombinant human erythropoietin on hematopoietic progenitors of chronic hemodialysis patients in vitro and in vivo. Int J Cell Cloning. 1989 Jul;7(4):257-63.
16	Mitani K, Miyazono K, Urabe A, Takaku F. Karyotypic changes during the course of blastic crisis of chronic myelogenous leukemia. Cancer Genet Cytogenet. 1989 Jun;39(2):299-300.
15	Hino M, Tojo A, Miyazono K, Miura Y, Chiba S, Eto Y, Shibai H, Takaku F. Characterization of cellular receptors for erythroid differentiation factor on murine erythroleukemia cells. J Biol Chem. 1989 Jun 15;264(17):10309-14.
14	Kuwaki T, Kitamura T, Tojo A, Matsuki S, Tamai Y, Miyazono K, Takaku F. Characterization of human interleukin-3 receptors on a multi-factor-dependent cell line. Biochem Biophys Res Commun. 1989 May 30;161(1):16-22.
13	Kovacina KS, Steele-Perkins G, Purchio AF, Lioubin M, Miyazono K, Heldin CH, Roth RA. Interactions of recombinant and platelet transforming growth factor-β1 precursor with the insulin-like growth factor II/mannose 6-phosphate receptor. Biochem Biophys Res Commun. 1989 Apr 14;160(1):393-403.
12	Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W, Heldin CH. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature. 1989 Apr 13;338(6216):557-62.
11	Miyazono K, Heldin CH. Role for carbohydrate structures in TGF-β1 latency. Nature. 1989 Mar 9;338(6211):158-60.
10	Miyazono K, Heldin CH. High-yield purification of platelet-derived endothelial cell growth factor: structural characterization and establishment of a specific antiserum. Biochemistry. 1989 Feb 21;28(4):1704-10.
9	Kitamura T, Tojo A, Kuwaki T, Chiba S, Miyazono K, Urabe A, Takaku F. Identification and analysis of human erythropoietin receptors on a factor-dependent cell line, TF-1. Blood. 1989 Feb;73(2):375-80.
8	Kobayashi Y, Okabe T, Ozawa K, Chiba S, Hino M, Miyazono K, Urabe A, Takaku F. Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: a preliminary report. Am J Med. 1989 Feb;86(2):178-82.
7	Heldin CH, Miyazono K, Claesson-Welsh L, Westermark B. Growth regulatory proteins from human platelets. Princess Takamatsu Symp. 1989;20:81-92.
6	Hino M, Tojo A, Miyazono K, Urabe A, Takaku F. Effects of type β transforming growth factors on haematopoietic progenitor cells. Br J Haematol. 1988 Oct;70(2):143-7.
5	Miyazono K, Hellman U, Wernstedt C, Heldin CH. Latent high molecular weight complex of transforming growth factor β1. Purification from human platelets and structural characterization. J Biol Chem. 1988 May 5;263(13):6407-15.
4	Miyazono K, Okabe T, Urabe A, Takaku F, Heldin CH. Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem. 1987 Mar 25;262(9):4098-103.
3	Miyazono K, Okabe T, Ishibashi S, Urabe A, Takaku F. A platelet factor stimulating the proliferation of vascular endothelial cells. Partial purification and characterization. Exp Cell Res. 1985 Aug;159(2):487-94.
2	Miyazono K, Okabe T, Urabe A, Yamanaka M, Takaku F. A platelet factor that stimulates the proliferation of vascular endothelial cells. Biochem Biophys Res Commun. 1985 Jan 16;126(1):83-8.
1	Miyazono K, Okazaki T, Uchida S, Totsuka Y, Matsumoto T, Ogata E, Terakawa K, Kurihara N, Takeda T. Propylthiouracil-induced diffuse interstitial pneumonitis. Arch Intern Med. 1984 Sep;144(9):1764-5.